Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 29, 2022 | Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares | DGAP-News: Mainz BioMed N.V. / Key word(s): Capital Increase Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares 28.01... |
| Jan 28, 2022 | Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares | BERKELEY, Calif. and MAINZ, Germany, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today... |
Reviews 0
FAQ about Dhyān
What has the press written about Dhyān?
Parsers VC has collected 3 articles mentioning Dhyān, among them “Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase A...” (Jan 29, 2022) and “Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase A...” (Jan 28, 2022).
Is Dhyān still active?
Yes, Dhyān is active; its latest activity on Parsers VC dates from Jan 29, 2022.